MAPT and Alzheimer disease: Together our results highlight the capability of rotenone exposure mimic dysfunction related with the early stages of AD possibly by enhancing ROS synthesis and suggest overall decrease in neuron environment toxicity, measured by protein carbonyls, H2O2 levels and Tau hyperphosphorylation, following the formation of Tau aggregates.